Alpha Tau Medical Ltd (DRTS) Stock Analysis & Investment Frameworks
Alpha Tau Medical Ltd (DRTS) stock analysis on Invetso. Review Alpha Tau Medical Ltd’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Alpha Tau Medical Ltd Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Biotechnology
- Country: IL
Alpha Tau Medical Ltd Key Financial Metrics
- Market Cap: $1.27B
- Revenue: $N/A
- ROE: -138.12%
- ROIC: -40.04%
- Dividend Yield: N/A
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.